• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Sheffield table for primary prevention of coronary heart disease: corrected.

作者信息

Ramsay L E, Haq I U, Jackson P R, Yeo W W

出版信息

Lancet. 1996 Nov 2;348(9036):1251. doi: 10.1016/s0140-6736(05)65536-5.

DOI:10.1016/s0140-6736(05)65536-5
PMID:8898071
Abstract
摘要

相似文献

1
The Sheffield table for primary prevention of coronary heart disease: corrected.用于冠心病一级预防的谢菲尔德表：校正版。
Lancet. 1996 Nov 2;348(9036):1251. doi: 10.1016/s0140-6736(05)65536-5.
2
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease.
Lancet. 1996 Feb 17;347(8999):466-7; author reply 468-9.
3
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease.
Lancet. 1996 Feb 17;347(8999):466; author reply 468-9.
4
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease.用于预防冠心病的胆固醇降低的谢菲尔德风险与治疗表。
Lancet. 1996 Feb 17;347(8999):468; author reply 468-9.
5
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease. GISSI-Prevenzione Investigators.
Lancet. 1996 Feb 17;347(8999):467-8; author reply 468-9.
6
Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table.针对冠心病一级预防的降脂药物治疗：更新后的谢菲尔德表
Lancet. 1996 Aug 10;348(9024):387-8. doi: 10.1016/s0140-6736(96)05516-x.
7
Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation.基于实验室的风险评分计算，对新型谢菲尔德表和改良的英国联合学会冠心病风险预测图进行比较评估。
Postgrad Med J. 2002 May;78(919):269-72. doi: 10.1136/pmj.78.919.269.
8
Drug therapy for coronary heart disease: the Sheffield table.
Lancet. 1997;350(9094):1853-4. doi: 10.1016/S0140-6736(05)63673-2.
9
Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease.用于冠心病一级预防的胆固醇降低的谢菲尔德风险与治疗表。
Lancet. 1995 Dec 2;346(8988):1467-71. doi: 10.1016/s0140-6736(95)92477-9.
10
Drug therapy for coronary heart disease: the Sheffield table.冠心病的药物治疗：谢菲尔德表格
Lancet. 1997;350(9094):1852-3. doi: 10.1016/s0140-6736(05)63672-0.

引用本文的文献

1
FRAX and the assessment of fracture probability in men and women from the UK.FRAX与英国男性和女性骨折概率评估
Osteoporos Int. 2008 Apr;19(4):385-97. doi: 10.1007/s00198-007-0543-5. Epub 2008 Feb 22.
2
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden.男性和女性骨质疏松症的干预阈值：一项基于瑞典数据的研究
Osteoporos Int. 2005 Jan;16(1):6-14. doi: 10.1007/s00198-004-1623-4. Epub 2004 Apr 22.
3
Ethics of evidence based medicine in the primary care setting.基层医疗环境中循证医学的伦理问题。
J Med Ethics. 2004 Apr;30(2):151-5. doi: 10.1136/jme.2003.003434.
4
Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey.降低血脂对预防冠心病的人群影响：来自1995年苏格兰健康调查的数据。
Heart. 2001 Sep;86(3):289-95. doi: 10.1136/heart.86.3.289.
5
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.HMG-CoA还原酶抑制剂（他汀类药物）治疗的成本效益与冠心病风险及药物治疗成本的关系。
Heart. 1999 Sep;82(3):325-32. doi: 10.1136/hrt.82.3.325.
6
Measuring serum total cholesterol: do vascular surgeons know what they are doing?测量血清总胆固醇：血管外科医生知道自己在做什么吗？
Ann R Coll Surg Engl. 1999 Jan;81(1):32-6.
7
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.弗雷明汉风险函数对北欧人群是否有效？高危男性绝对冠心病风险估计方法的比较。
Heart. 1999 Jan;81(1):40-6. doi: 10.1136/hrt.81.1.40.
8
Cholesterol screening and management guidelines. Having several guidelines is confusing.胆固醇筛查与管理指南。有多个指南令人困惑。
BMJ. 1999 Apr 24;318(7191):1140. doi: 10.1136/bmj.318.7191.1140a.
9
Implications of applying widely accepted cholesterol screening and management guidelines to a British adult population: cross sectional study of cardiovascular disease and risk factors.将广泛认可的胆固醇筛查与管理指南应用于英国成年人群体的影响：心血管疾病及风险因素的横断面研究
BMJ. 1998 Oct 24;317(7166):1125-30. doi: 10.1136/bmj.317.7166.1125.